Introduction
Approximately 3 ± 6% of the tumors of the head and neck region occur in the major and minor salivary glands (Shah and Ihde, 1990) and of these, the benign pleomorphic adenoma is the most common tumor (Waldron, 1991) . Previous studies have shown that about 50 ± 80% of the pleomorphic adenomas display clonal chromosomal abnormalities (Sandros et al., 1990; Bullerdiek et al., 1993) . Two major cytogenetic subgroups with abnormal karyotypes can be distinguished, i.e. tumors with rearrangements of 8q12 or 12q13 ± 15. Whereas the t(3;8)(p21;q12) is the most frequently observed translocation, many dierent chromosome segments can act as translocation partners of both 8q12 and 12q13 ± 15 (Sandros et al., 1990; Bullerdiek et al., 1993) . The short arm of chromosome 9, with breakpoints in the segment 9p12 ± 24, is the preferential translocation partner of chromosome 12q13 ± 15 . The reason for the variability of the breakpoints in 9p is likely to be due to the limited resolution of the banding pattern in 9p12 ± 24 and 12q13 ± 15, making it almost impossible to determine the exact locations of the breakpoints with certainty.
Recently, HMGIC was identi®ed as the gene consistently aected in pleomorphic adenomas of the salivary glands and in a variety of other benign mesenchymal tumor types characterized by 12q13 ± 15 aberrations (Schoenmakers et al., 1995b; Ashar et al., 1995) . The location of the breakpoints with respect to HMGIC is variable and occur 5' and 3' to HMGIC as well as recurrently in the very large, third intron of the gene, resulting in the separation of the three predicted DNA binding domains in the amino-terminal region from the acidic, carboxy-terminal domain of HMGIC. HMGIC is a member of the high mobility group (HMG) protein gene family which comprises proteins that are heterogeneous, nonhistone components of chromatin (Grosschedl et al., 1994) . HMGIC expression is tightly regulated, with the highest expression in fetal tissues and undetectable expression by Northern blot analysis of the normal full-length transcript in normal adult tissues. HMGIC binds in the minor groove of DNA and has been suggested to act as an architectural factor (Wole, 1994) in the nuclear scaold (Saitoh and Laemmli, 1994; Tjian and Maniatis, 1994) . The causal relationship between genetic aberrations aecting HMGIC and aberrant growth control in benign tumors remains to be established. Of interest to note in this context is the observation that inactivation of both HMGIC alleles in mice results in the so-called Pygmy phenotype with as most important feature, disrupted growth leading to dwar®sm . These data demonstrate the important role of the HMGI proteins in mammalian growth and development.
So far, four dierent fusion partner genes of HMGIC have been identi®ed. The ®rst one is the LPP gene (Schoenmakers et al., 1995b; Ashar et al., 1995; Petit et al., 1996) which is located on chromosome 3q27 ± q28 and encodes a protein containing LIM domains. The second one is a postulated gene on chromosome 15q24 which has not yet been characterized in detail but which is predicted to encode a protein with a serine ± threonine-rich domain . The third one is the mitochondrial aldehyde dehydrogenase ALDH2 gene on chromosome 12q24.1, which was found as translocation partner gene of HMGIC in a uterine leiomyoma (Kazmierczak et al., 1995) . In pleomorphic adenoma, the ®rst known fusion partner gene of HMGIC is the FHIT gene, which has been mapped to chromosome 3p14.2 (Geurts et al., 1997a) . The pathogenetic relevance of the fusion partners remains to be elucidated. The diversity in chromosomal segments that have been found to participate in translocations could indicate that the critical sequences are abundantly present in the human genome. However, it has not yet been possible to reliably identify a common structural or functional denominator for the limited number of known translocation partner genes.
Here, we present the results of 3'-RACE and RT ± PCR experiments leading to the identi®cation and subsequent characterization of a novel fusion partner gene of HMGIC in pleomorphic adenomas of the salivary glands.
Results

Cytogenetic and FISH analysis
Conventional cytogenetic analysis of adenoma CG575 revealed an apparently normal karyotype (Figure 1a) . However, detailed analysis of two metaphases with elongated chromosomes suggested that one of the two chromosome 12 homologs was somewhat shorter than the other (data not shown). The banding pattern of the 12q-marker suggested an interstitial deletion of band 12q15. Hybridization with a chromosome 12 painting probe did not reveal translocation of chromosome 12 material to any other chromosome. Adenoma CG732 had a pseudodiploid karyotype with an ins(9;12) (p23;q12q15) as the sole anomaly ( Figure 1a ). Hybridization with painting probes for chromosomes 9 and 12 con®rmed the insertion of 12q material into 9p.
To test whether both cases with 12q13 ± 15 abnormalities belonged to the group of pleomorphic adenomas with rearrangements of HMGIC we used two YAC clones, 341C1 and 452E1 (data not shown), which contain the complete HMGIC gene. FISH analysis using these YACs revealed signals on the normal chromosome 12 as well as on the der(9) and der(12) chromosomes, demonstrating that the HMGIC YACs spanned the 12q breakpoints in both tumors (Figure 1b and c) . The signals on the der(9) were in both cases located close to pter in band 9p23. The FISH data thus show that CG575 has a hidden ins(9;12). This case may therefore be equivalent to CG732 in which a larger segment of 12q is inserted into the same part of 9p. Collectively, the FISH data from both tumors raise the possibility that the target gene on 12q is HMGIC and that the insertions aect the same gene on 9p.
To further characterize the 12q breakpoints in adenoma CG575 we also hybridized with YACs containing the closely linked genes SAS ± CDK4 (YAC 751A4) and MDM2 (YAC 975D8) which map centromeric and telomeric of HMGIC, respectively. Both YACs gave only signals on the two chromosomes 12, demonstrating that the second chromosome 12 breakpoint is distal to SAS ± CDK4. As expected from cytogenetics, the SAS ± CDK4 signal in CG732 was transposed to 9p while the MDM2 signal remained on the der(12) (data not shown).
Detection of an HMGIC fusion transcript
In an attempt to determine whether the target gene on 12q is indeed the HMGIC gene, 3'-RACE analysis was performed. Analysis of adenoma CG575 resulted in the isolation of a 814 bp PCR product, 773 bp of which were deposited at GenBank (accession number AF022215), representing the 3'-RACE product devoid of non-speci®c cloning and PCR tails. Nucleotide sequence analysis of this product revealed that it contains 21 nucleotides of exon 4 of HMGIC (nucleotides 1073 ± 1093 in wild-type HMGIC accession number U28749) and 752 nucleotides from the last exon of NFIB and part of its 3'-UTR (nucleotides 1455 ± 2206 in wild-type NFIB as described in this manuscript and also available under accession number U85193). The sequence diversion point was thus found immediately downstream of HMGIC exon 4, suggesting a rearrangement within intron 4 of the HMGIC gene. As a result, the acidic tail of HMGIC was separated from the three DNA binding domains and the spacer domain. In phase with the HMGIC reading frame, the ectopic sequences appeared to contain a stop codon after ®ve codons, adding only ®ve, ectopic amino acid residues (SWYLG) to the truncated HMGIC protein.
Identi®cation of NFIB as fusion partner gene of HMGIC To establish the nature and origin of the ectopic sequences, genomic clones corresponding to these were isolated from a phage library using PCH203 as molecular probe. This probe was synthesized with the PCR primer set PCH203-upper and -lower, which were developed on the basis of the ectopic sequences. Three clones were obtained which were characterized by restriction enzyme and partial nucleotide sequence analysis. A routine BLAST search by e-mail at blast@ncbi.nlm.gov revealed that the ectopic sequences, fused to HMGIC sequences, were 95% identical to hamster clone pNFI ± Red1 which encodes nuclear factor I (NFI) protein (Gil et al., 1988) , suggesting that the ectopic sequences were derived from the human NFIB gene.
The chromosomal origin of the ectopic sequences was determined by analysis of the NIGMS human ± rodent somatic hybrid mapping panel 2 (Coriell Cell Repositories) (data not shown). From these studies, it appeared that the ectopic sequences were derived from chromosome 9. For subsequent ®ne mapping, CH203-speci®c YAC clones 42G9, 100C6, and 246C4 were isolated from the CEPH mark 1 library and YAC clones 783H10, 800A7, 806F7, 912E9, and 924D12 from the CEPH mark 3 library using the ectopicspeci®c amplimer set PCH203 (Figure 2 ). By internetmediated YAC query at http://www-genome.wi.mit.edu /cgi-bin/contig/YAC info followed by STS information retrieval at the Human Genome Database, the YAC clones were found to map on the short arm of chromosome 9, at 9p23, i.e. the region preferentially aected in pleomorphic adenomas with 9p involvement. This was also con®rmed by FISH using several YACs, including YAC 912E9 which contains the entire NFIB gene. FISH mapping of YAC 912E9 on metaphase chromosomes from both CG575 and CG732 resulted in signals only on the chromosome 9 homologs. There was no evidence of insertion of chromosome 9 material into chromosome 12 in any of the tumors. In CG732, there was a split signal on the der(9) chromosome caused by the insertion of 12q sequences into 9p23 (Figure 1d ), whereas in CG575 the insertion was at the border of visibility and was only possible to detect in three metaphases with elongated chromosomes (data not shown). FISH analysis thus con®rm that in both cases there are breakpoints in the NFIB containing YAC.
Since only the incomplete open reading frame of the human NFIB gene had been published (Qian et al., 1995) , overlapping cDNA clones were isolated to obtain the complete coding region. In order to isolate these overlapping cDNA clones, two dierent approaches were followed. As a ®rst approach, sequences derived from the ends of the published incomplete reading frame were used as starting points for the isolation of overlapping clones by repeated BLAST searches. After each round of BLAST screening, the ends of the composite contig constructed with the retrieved anonymous EST (Expressed Sequence Tagged) clones were used as new starting points for additional rounds of BLAST screening. As a second Figure 1 (a) Partial G-banded karyotypes of adenoma CG575 and CG732 showing the der(9) and der(12) markers (to the right) as well as their normal homologs (to the left). (b and c) FISH-analysis of tumor chromosomes from CG575 and CG732 using the HMGIC containing YAC 341C1 as probe. Co-hybridization of YAC 341C1 (green signal) and alpha satellite probes for chromosomes 9 and 12 (red signal) resulted in green hybridization signals on the normal chromosome 12, the der(12), and the der(9), demonstrating that this YAC spans the 12q breakpoint in both tumors. Note that in (b), the hybridization signal on the der(12) is weaker than on the normal chromosome 12. (d) FISH mapping of the 9p insertion breakpoint in adenoma CG732: Co-hybridization of the NFIB containing YAC 912E9 (green signal) with alpha satellite probes for chromosomes 9 and 12 (red signals) resulted in NFIB signals only on the normal 9 and the der(9). Note a split signal at the insertion breakpoint on the der(9). Chromosomes were counterstained in blue with 4,6-diamino-2-phenylindole (DAPI). Fluorescence signals were digitalized, processed and analysed using the ProbeMaster FISH image analysis system (Perceptive Scienti®c Instruments, Houston, Texas) approach, an oligo-(dT)-and randomly primed cDNA library (Clontech # HL1133b) was screened. Eight overlapping cDNA clones were retrieved, i.e. HFBCP66, U07810, 130995, 133643, 133980, 145106, 178178 , and C6A07. Screening of a cDNA library with a probe derived from C6A07 resulted in the isolation of a cDNA (clone pCH294) and nucleotide sequence analysis of it indicated that it contained the 5'-coding part of the NFIB gene (®rst ®ve codons and¯anking 5'-UTR). Using the nucleotide sequence data of the nine cDNA clones, a consensus composite NFIB cDNA of about 2.5 kb could be established ( Figure  3a) . The cDNA appeared to contain an open reading frame of 1260 nucleotides coding for a protein of 420 amino acid residues. It should be noted that the NFIB transcript is about 8.5 kb in size but since only the coding sequences are relevant to the content of the manuscript, characterization of the NFIB mRNA has been limited to only that region. The composite human NFIB cDNA shows a high sequence homology to the chicken NFIB2 splice variant (Rupp et al., 1990) and, possibly constitutes a similar splice variant of the human NFIB gene. The nucleotide sequence of the composite cDNA of NFIB has been deposited at GenBank (Accession number: #U85193). Using data of the phage genomic clones described above, it was established that the ectopic sequences (cf. PCH203) were derived from the last coding exon (LCE) of NFIB.
Expression pattern of the NFIB gene
Commercially obtained, polyA + multiple tissue Northern blots were screened with the PCR probe PCH203. A single transcript of approximately 8.5 kb was detected in heart, colon, small intestine, ovary, prostate, and, at low levels, in peripheral blood leukocyte, testis, and spleen, whereas expression levels in pancreas, kidney, skeletal muscle, liver, lung, placenta, brain, and thymus were below the detection limit (Figure 4) . Furthermore, no transcripts were detected that could represent naturally occurring, alternatively spliced mRNA isoforms. Since no specific NFIB signal could be detected on a salivary gland tissue derived total RNA Northern blot, more sensitive RT ± PCR analysis was performed to investigate the possible wild type NFIB expression in this tissue. These experiments revealed that the NFIB gene is also expressed in normal salivary gland tissue (data not shown).
Diversity of HMGIC/NFIB fusion transcripts expressed in pleomorphic adenomas
To investigate whether NFIB and HMGIC are also aected in adenomas with cytogenetically detectable 9;12-rearrangements, we analysed a second adenoma, CG732, with an ins(9;12)(p23;q12q15) by RT ± PCR. Using the appropriate HMGIC and NFIB-speci®c primers, RT ± PCR resulted in a 450 bp HMGIC/NFIB product in tumor CG575 (Figure 3b, lane 3) and a 417 bp HMGIC/NFIB product in tumor CG732 ( Figure  3b, lane 7) . No reciprocal, NFIB/HMGIC, fusion transcripts were detected in either of the tumors (Figure 3b, lanes 2 and 6) . Nucleotide sequence analysis of both HMGIC/NFIB products revealed that in adenoma CG575, a fusion had occurred between the fourth exon of HMGIC and the last coding exon of NFIB (Figure 3c ). These results con®rm the data obtained in the 3'-RACE experiments. In adenoma CG732, a fusion had occurred between the third exon of HMGIC and the last coding exon of NFIB (Figure 3d) .
The detection of HMGIC/NFIB transcripts in both tumors raised the question as to whether normal transcripts of these genes were also expressed. In RT ± PCR experiments, using the appropriate primer sets (Figure 3) , expression of normal HMGIC transcripts could not be demonstrated in adenoma CG575 (Figure 3b , lane 1) whereas in tumor CG732, an RT ± PCR product of 508 bp was detected, indicating that normal HMGIC transcripts are expressed (Figure 3b, lane 5) . In both tumors, a 1340 bp RT ± PCR product was detected with the appropriate NFIB primers, suggesting expression of normal NFIB transcripts (Figure 3b, lanes 4 and 8) . Nucleotide sequence analysis of the coding regions of the normal HMGIC and NFIB transcripts revealed that the reading frames were devoid of mutations (data not shown). Since the HMGIC and NFIB genes were not sequenced in their entirety, it remains to be established whether changes have occurred in the noncoding sequences. 
Discussion
In the present study, we have identi®ed NFIB as a novel translocation partner gene of HMGIC in pleomorphic adenomas with chromosome 12q13 ± 15 aberrations. The NFIB gene was mapped to chromosome band 9p23, a region known to be the most frequent translocation partner of chromosome 12q13 ± 15 . Analysis of the HMGIC/ NFIB fusion transcripts that were detected in the two tumors studied revealed that in each case, the last coding exon of the NFIB gene was fused to sequences derived from HMGIC. In tumor CG732, the rearrangement had occurred within the very large, third intron of HMGIC, thus separating the three amino-terminal DNA-binding domains from the spacer domain and the carboxy-terminal acidic tail. In tumor CG575, however, the rearrangement in the HMGIC gene was in NFIB is a member of the human nuclear factor I (NFI) gene family, which has been mapped to chromosome 9p24.1 (Qian et al., 1995) . Structurally, members of this family contain DNA binding and dimerization domains in their amino-terminal regions and proline-rich, transactivating domains in their carboxy-termini. Human nuclear factor I (NFI) was ®rst identi®ed and puri®ed as a 47 kDa stimulatory protein required for ecient initiation of adenovirus DNA replication (Nagata et al., 1982) . It was later shown to be involved in the transcriptional regulation of a variety of viral and cellular genes. While the mechanism of transcriptional activation is still unknown, NFI binding sites have been found in a wide variety of genes (Raymondjean et al., 1988; Inoue et al., 1990; Zorbas et al., 1992) , and NFI genes are expressed in many dierent tissues (Cereghini et al., 1987; Paonessa et al., 1988; Apt et al., 1994) . At present, the NFI gene family consists of four members, i.e. NFIA, NFIB, NFIC, and NFIX. The human NFIA and NFIB genes have been mapped to positions 1p31.2 ± p31.3 and 9p24.1, respectively, whereas the NFIC and NFIX genes both map to 19p13.3 (Qian et al., 1995) .
In adenomas, breakpoints have thusfar been assigned either upstream of HMGIC (Ad-302 SV40), within intron 3 (Ad-211 SV40, Ad-295 SV40 and CG592), within intron 4 (CG575), within the 3'-UTR (Ad-312 SV40), or downstream of HMGIC (Ad-263 SV40 and Ad-386 SV40) by FISH and/or 3'-RACE experiments (Schoenmakers et al., 1995b; Geurts et al., 1997a) . The alternative locations for the chromosome breakpoints within the HMGIC gene found in the two adenomas studied are consistent with previous studies of benign tumors with chromosome 12 aberrations (Schoenmakers et al., 1995b; Ashar et al., 1995; Schoenberg Fejzo et al., 1996) .
The breakpoints within the NFIB gene were found to occur in the 3'-region of the gene for both tumors, i.e. in the intron preceding the last coding exon of NFIB. This exon encodes only for the last ®ve amino acids (SWYLG) of the transactivating domain of the NFIB protein. It has been reported (Roulet et al., 1995) , that these ®ve amino acids are critical for the proper functioning of the transcription factor.
The observation that the NFIB gene is a recurrent translocation partner gene of HMGIC in pleomorphic adenomas with chromosome 12q13 ± 15 involvement and that in both tumors studied only HMGIC/NFIB fusion transcripts could be detected but not their reciprocal forms, may be indicative for a causal relationship between the corresponding fusion proteins and pleomorphic adenoma pathogenesis. Although RT ± PCR results exclude a possible pathogenetical role for NFIB/HMGIC fusion transcripts, one can not exclude the possibility that an otherwise truncated NFIB gene plays such a role in pleomorphic adenomas.
Recently Tkachenko et al. (1997) proposed a model for lipoma formation in which the absence of expression of wild type HMGIC depends on the gain of a transcriptional regulatory domain as a result of a chromosomal rearrangement. Since the presence vs absence of the HMGIC encoded spacer domain is the only molecular dierence between the two tumor specimens characterized here, our observations concerning wild type HMGIC expression within these tumors only ®ts this model in case the spacer domain contains such transcriptional regulatory domains. Since this putative function of the spacer domain seems rather unlikely, we expect that the observed dierences in wild type HMGIC expression most likely re¯ects dierences in tumor sampling.
The contribution of the NFIB sequences to pleomorphic adenoma pathogenesis is expected to be limited since only ®ve amino acid residues replace a major carboxy-terminal portion of HMGIC, i.e. the region including either the acidic domain or, alternatively, the acidic domain and the spacer domain. Our ®ndings are somewhat similar to those recently observed in a pleomorphic adenoma in which the FHIT gene (which maps to 3p14.2 (Ohta et al., 1996) ) was found to be fused to HMGIC as a result of a complex t(3;10;12) (Geurts et al., 1997a) . In this case, a reciprocal fusion between HMGIC and the FHIT gene results in the exchange of 26 amino acids of the acidic tail of HMGIC by 31 carboxy-terminal amino acids of the FHIT protein, which are encoded by exon 9 of FHIT. A similar observation has been made in a case of uterine leiomyoma, in which the mitochondrial aldehyde dehydrogenase gene (ALDH2) acted as fusion partner gene of HMGIC (Kazmierczak et al., 1995) . Since no common denominator can be identi®ed in the coding sequences of the fusion partner genes (FHIT, NFIB, and ALDH2), it is tempting to speculate that the importance of the fused sequences is limited and merely restricted to providing the necessary elements for proper translation of the hybrid transcripts, e.g. a translational stop codon and a polyadenylation signal. Based on these results, one could argue that the separation of the DNA binding domains from the carboxy-terminal acidic domain of HMGIC is the critical event. Fusion of the DNA binding domains of the HMGIC protein to well-de®ned functional domains, as described for instance for lipomas with t(3;12) (Petit et al., 1996) , may have to be explained in this manner as well. On the other hand, however, one should not exclude the possibility of alternative scenarios. Recently, we characterized a pleomorphic adenoma cell line in which the HMGIC rearrangement occurred within the 3' noncoding region of the gene, leaving the complete coding region of HMGIC intact (Geurts et al., 1997b) . In conclusion, the identi®cation of the NFIB gene as recurrent translocation partner gene of HMGIC in adenomas with involvement of chromosomes 9 and 12 further establishes the diversity in translocation partner sequences of HMGIC in benign tumors and adds support to the hypothesis that the HMGIC gene plays a central role in benign tumor development.
Materials and methods
Tumor material and cytogenetic and FISH analyses
Short-term, primary cultures were established from two primary pleomorphic adenomas, CG575 and CG732, as previously described (Nordkvist et al., 1994) . Cells from primary cultures were harvested after Colcemid exposure followed by hypotonic treatment and ®xation in methanol:acetic acid. Slides were subsequently G-banded and analysed according to the recommendations of the ISCN (1995) . FISH analysis of metaphase chromosomes was performed as previously described (RoÈ ijer et al., 1996) .
Isolation of genomic phage and YAC clones
Phage clones were isolated from a genomic library constructed with DNA from cell line LM-30.1/SV40 (Schoenmakers et al., 1995a) using lambdaFIX II as vector according to standard procedures. YAC clones were isolated from the CEPH human genomic YAC libraries mark 1 and 3 using a combination of PCR-based screening and colony hybridization analysis as previously described (Schoenmakers et al., 1995a) . YAC clones are indicated by their unique microtiter plate addresses. The experimental procedures for isolation and subsequent characterization of the YAC clones by pulsed-®eld gel electrophoresis (Chu et al., 1986) , Southern blot, hybridization and restriction mapping analysis, were exactly as described by Schoenmakers et al. (1994) .
RNA isolation and Northern blot analysis
Total RNA was isolated from primary adenomas CG575 and CG732 using TRIzol LS Reagent (GIBCO BRL) according to the supplier's instructions. Commercially obtained Northern blots (Clontech #7759 ± 1 and #7760 ± 1) of poly A + selected RNA from dierent human tissues (pancreas, kidney, skeletal muscle, liver, lung, placenta, brain, heart, peripheral blood leukocytes, colon, small intestine, ovary, testis, prostate, thymus, spleen) were screened with the NFIB-speci®c probe PCH203 according to the supplier's instructions. For normalization, human bactin cDNA was used as a probe.
3'-RACE analysis
Rapid ampli®cation of 3' cDNA-ends (3'-RACE) was performed using the 3'-exon trapping protocol of GIBCO BRL with slight modi®cations. For ®rst strand cDNA synthesis, adapter primer (AP2; 94M2363) AAG GAT CCG TCG ACA TC(T) 17 was used. For both initial and secondary rounds of PCR, the universal ampli®cation primer (UAP2; 95L736) CUACUACUACUAAAG-GATCCGTCGACATC was used as`reverse primer'. In the ®rst PCR round the following HMGIC-speci®c forward primers' were used: (i), 94N1501) 5'-CTTCA-GCCCAGGGACAAC-3' (exon 1); (ii), 94N701) 5'-CAA-GAGGCAGACCTAGGA-3' (exon 3); or (iii), 94M1892) 5'-AACAATGCAACTTTTAATTACTG-3' (3'-UTR). In the second round the following HMGIC-speci®c forward primers (nested primers as compared to those used in the ®rst round) were used: (i), 94N1502) 5'-CAUCAUCAUCA-UCGCCTCAGAAGAGAGGAC-3' (exon 1); (ii), 94N700) 5' -CAUCAUCAUCAUGT TCAGAAGAAGC CTGCT -3' (exon 4); or (iii), 94M1908) 5'-CAUCAUCAUCAUTT-GATCTGATAAGCAAGAGTGGG-3' (3'-UTR). CUA ± CAU-tailing of the nested, speci®c primers allowed the use of the directional CloneAmp cloning system (GIBCO BRL).
RT ± PCR analysis
RT ± PCR (reverse transcriptase reaction combined with polymerase chain reaction) was performed following the procedure described by Schoenmakers et al. (1995b) . Brie¯y, cDNA was synthesized from 5 mg of total RNA. Reverse transcription was performed according to the ®rst strand cDNA synthesis protocol from GIBCO BRL using NFIB-speci®c cDNA synthesis primer (35978 ± 001) 5'-AGTGCTGCAATTGCTGGTCT-3' and HMGIC-speci®c cDNA synthesis primer (95C3362) 5' TACAG-CAGTTTTTCACTA-3'. The primers used in the various experiments are listed in the legend to Figure 3 . The RT ± PCR products were directly subcloned into the pCR II vector (TA-cloning kit, Invitrogen #K2000-40) and subsequently used for sequence analysis. The following PCR reactions have been performed for each tumor: two PCR reactions to detect expression of normal HMGIC, HMGIC NFIB, NFIB HMGIC, and normal NFIB (in total eight PCR reactions, ®rst and second round of PCR). Three subclones of each reaction were sequenced.
PCR ampli®cation
All PCR ampli®cations were carried out in ®nal volumes of 100 ml containing 10 mM Tris-HCl pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 , 0.01% gelatine, 0.2 mM dNTP's, 20 pmole of each amplimer, 2.5 units of AmpliTaq (Perkin-Elmer Cetus), and template DNA, using a Pharmacia ± LKB Gene ATAQ controller or a Perkin Elmer DNA thermal cycler. For isolation of YACs, 100 ng (for YAC superpools) or 20 ng (for YAC pools) of template DNA was used together with 20 pmole of each amplimer (PCH203-upper (5'-GGGAAAAAGAAACACAACAA-3') and PCH203-lower (5'-TCAGTTTCTT-TCCTTTCTGC-3')). After initial denaturation for 5 min at 948C, 35 ampli®cation cycles were performed each consisting of denaturation for 1 min at 948C, annealing for 1 min at 608C and extension for 1 min at 728C. The PCR reaction was completed by a ®nal extension at 728C for 5 min. The results were evalulated by analysis of 10 ml of the reaction product on 6% polyacrylamide minigels.
Nucleotide sequence analysis
Nucleotide sequences were determined essentially according to the dideoxy chain termination method (Sanger et al., 1977) , using a T7 polymerase sequencing kit (Pharmacia LKB) or the dsDNA Cycle Sequencing System (GIBCO BRL). Sequencing results were obtained using an Automated Laser Fluorescent (ALF) DNA sequencer (Pharmacia Biotech) and standard 30 cm, 6% Hydrolink, Long Range gels (AT Biochem). The nucleotide sequences were analysed using the sequence analysis software Genepro (Riverside Scienti®c) and Lasergene (DNASTAR, Inc.). All oligonucleotides were purchased from Pharmacia Biotech.
